ArticleFrontiers in immunology2026
Multimodal AI reading of genetic complexity and residual marrow composition in acute promyelocytic leukemia.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute promyelocytic leukemia (APL) is defined by its genetics, yet interphase fluorescence Methods: We describe two image-derived readouts for a retrospective cohort of patients with APL. A genetic complexity axis classifies the FISH fusion signal pattern and flags any additional cytogenetic abnormality (ACA) beyond the t(15;17), directly from raw, unarranged metaphase spreads. A marrow composition axis extends a cytomorphology pipeline, built on frozen DinoBloom embeddings and a per-cell classification head directly supervised on an annotated subset, from promyelocyte detection to a seven-class differential count. From this composition, we compute a residual hematopoiesis index, the model-estimated fraction of non-leukemic nucleated marrow cells, so that a higher value indicates a larger non-leukemic fraction. The index is a morphology-derived surrogate for residual non-leukemic marrow composition and carries no immune-phenotypic information. The association between the two axes is computed directly from patient-level, out-of-fold branch outputs; a small, three-node fusion module over the two genetic and one composition readout supports only a secondary, exploratory analysis, reported in the Supplementary Material. The cohort held 700 patients with smear, FISH, and karyotype linked per patient, of whom 650 had complete clinical annotation; we evaluated each branch with patient-stratified fivefold cross-validation, five repeats, pooled out-of-fold, and report bootstrap confidence intervals (CIs) over patients. Diagnostic flow cytometry was retrievable for 118 patients, and 80 slides were re-scanned with fields independently re-selected, to check the index against an external measurement and against itself. Results: The fusion-pattern classifier had a macro-averaged F1 of 0.82 across the five signal classes, and the karyotype ACA reader had an area under the curve (AUC) of 0.86. The residual hematopoiesis index had a median of 0.42 (interquartile range, IQR, 0.29 to 0.58) across the cohort, tracked the flow-derived non-blast fraction at a Spearman correlation of 0.80 (95% CI 0.72 to 0.86) in the 118 patients with flow data, and had an intraclass correlation of 0.91 on re-scanned slides. Genetic complexity and the residual hematopoiesis index were associated at a Spearman Conclusion: Image-derived genetic complexity was positively associated with the residual hematopoiesis index, and the association persisted under the adjustments and substitutions applied to it. These findings describe a cross-sectional association in a single-center, retrospective cohort, not a validated diagnostic or risk tool. The residual hematopoiesis index summarizes morphology alone, its agreement with flow cytometry is supportive rather than confirmatory, and the secondary DS analysis drew on a smaller, clinically annotated subset of the cohort rather than on every patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.